The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1643
ISSUE1643
February 7, 2022
Glycopyrrolate (Dartisla ODT) for Peptic Ulcer Symptoms
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Glycopyrrolate (Dartisla ODT) for Peptic Ulcer Symptoms
February 7, 2022 (Issue: 1643)
The FDA has approved adjunctive treatment with
Dartisla ODT (Edenbridge), a new orally disintegrating
tablet (ODT) formulation of the anticholinergic drug
glycopyrrolate, to reduce symptoms of a peptic ulcer.
Glycopyrrolate oral tablets (Robinul,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.